Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 11/2022

02.09.2022 | Correction

Correction: Intrapandemic regional anesthesia as practice: a historical cohort study in patients undergoing breast cancer surgery

verfasst von: Ariane Clairoux, MD, FRCPC, Maxim Soucy-Proulx, MD, François Pretto, MD, Victoria Courgeon, MD, Maxime Caron-Goudreau, MD, Rami Issa, MD, Beng, FRCPC, Marie-Ève Bélanger, MD, PGdip(ed), FRCPC, Véronique Brulotte, MD, MSc, FRCPC, Olivier Verdonck, MD, MSc, DESAR, Moulay Idrissi, BEng, MSc, Annik Fortier, MSc, Philippe Richebé, MD, PhD, DESAR

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Excerpt

In Table 2, column “Intrapandemic group,” the denominators have been corrected to reflect patients who received general anesthesia vs regional anesthesia and sedation (n = 24 and n = 80, respectively)
Table 2
Intraoperative data
Outcome
Prepandemic group
N = 106
Intrapandemic group
N = 104
Absolute difference (95% CI)
P value
General anesthesia:
   
77% (69 to 85)
< 0.001a
 Yes
106/106 (100%)
24/104 (23%)
   
 No
0/106 (0%)
80/104 (77%)
   
General anesthesia:
     
< 0.001a
 Paravertebral block
0/106 (0%)
5/24b (21%)
-21% (-37 to -5)
 
 PEC2 block
34/106 (32%)
11/24b (46%)
-14% (-36 to 8)
 
 Serratus block
1/106 (1%)
5/24b (21%)
-20% (-36 to -4)
 
 ESP block
1/106 (1%)
1/24b (4%)
-3% (-11 to 5)
 
 Without block
70/106 (66%)
2/24b (8%)
58% (43 to 72)
 
Regional anesthesia and sedation:
     
NA
 Paravertebral block
 
78/80c (98%)
   
 ESP block
 
1/80c (1%)
   
 Epidural
 
1/80c (1%)
   
TIVA
2/106 (2%)
0/24b (0%)
2% (-14 to 7)
1.00d
Volatile
104/106 (98%)
24/24b (100%)
-2% (-7 to 14)
1.00d
Block failure
 
3/80c (4%)
 
NA
Total intraoperative fentanyl (µg)
121 [99–200]
50 [0–150]
50 (36 to 78)
< 0.001e
Number of intraoperatively administered PONV prophylaxis medicationsf
     
< 0.001a
 0
4/106 (4%)
16/104 (15%)
-12% (-19 to -4)
 
 1
11/106 (10%)
43/104 (41%)
-31% (-42 to -20)
 
 2
63/106 (59%)
32/104 (31%)
29% (16 to 42)
 
 3
28/106 (26%)
13/104 (13%)
14% (3 to 24)
 
PONV prophylaxis with 2 or more treatments
91/106 (86%)
45/104 (43%)
43% (31 to 54)
< 0.001a
All numbers are represented as median [interquartile range] or as n/total N (%); differences are (prepandemic – intrapandemic)
aChi square test, difference in percentages (95% CI)
bThe denominator reflects those patients on the intrapandemic group who received general anesthesia
cThe denominator reflects those patients on the intrapandemic group who received regional anesthesia and sedation
dFisher’s exact test, difference in percentages (exact 95% CI)
eMann–Whitney–Wilcoxon test, difference in medians (95% CI) [estimated using the Hodges–Lehmann method]
fDexamethasone, haloperidol, ondansetron, or aprepitant
CI = confidence interval; ESP = erector spinae plane; PEC2 = plane block between pectoralis minor and serratus anterior; PONV = postoperative nausea and vomiting; TIVA = total intravenous anesthesia
Metadaten
Titel
Correction: Intrapandemic regional anesthesia as practice: a historical cohort study in patients undergoing breast cancer surgery
verfasst von
Ariane Clairoux, MD, FRCPC
Maxim Soucy-Proulx, MD
François Pretto, MD
Victoria Courgeon, MD
Maxime Caron-Goudreau, MD
Rami Issa, MD, Beng, FRCPC
Marie-Ève Bélanger, MD, PGdip(ed), FRCPC
Véronique Brulotte, MD, MSc, FRCPC
Olivier Verdonck, MD, MSc, DESAR
Moulay Idrissi, BEng, MSc
Annik Fortier, MSc
Philippe Richebé, MD, PhD, DESAR
Publikationsdatum
02.09.2022
Verlag
Springer International Publishing
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 11/2022
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-022-02293-2

Weitere Artikel der Ausgabe 11/2022

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 11/2022 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.